web analytics
6.3 C
Munich
Sunday, April 18, 2021

The Rise of Cerebain Biotech Corp OTCMKTS: CBBT) PKG LOI

Cerebain Biotech Corp OTCMKTS: CBBT) has been running up the charts in recent weeks quickly attracting legions of shareholders and emerging as a volume leader in small caps as the Company is in the process of acquiring PKG, Inc., a developer, and manufacturing company for system-level devices with expertise in human-machine interfaces focusing on healthcare, industrial, aerospace and government products.

For the past 30 years PKG has been a major contributor in designing and manufacturing numerous and diverse devices for Fortune 500 companies, mid-size organizations, and start-up businesses. With complete in-house vertical integration, PKG provides its customers with all of their product development needs from R&D, design & development, verification & validation, final product manufacturing, product testing, service and warranty and end of life product support and transitioning.

Cerebain Biotech Corp OTCMKTS: CBBT) is a development-stage medical device company focused on the creation and clinical development of its patent-pending minimally invasive implantable device and a synthetic drug solution. The device leverages the clinically observable, positive impact that Omentum stimulation has on cognitive function as related to dementias, and in particular, Alzheimer’s disease. Generally described as a protective layer in the abdomen, the omentum covers the intestines, hangs on to the stomach and can be lifted like a flap. While the omentum is not a well-recognized body part, it can play important healing and protective roles for its host. The omentum has abundant blood and lymphatic vessels, and can move flexibly throughout the abdomen to protect organs from threat and injury. Additionally, it contains the largest supply of stem cells in the adult body. Because of its abundant blood supply, surgeons have long used the omentum to patch internal injuries sustained to other parts of the body. Cerebain is evaluating the effect of omental stimulation at different intervals and levels of stimulation to determine the device’s ability to slow, stop or reverse the progression of Alzheimer’s Disease on patients.

Cerebain Biotech took off in September after the Company entered into an LOI to purchase the assets of PKG, Inc. (PKG). PKG, Inc. was established in 1989 and is a privately held corporation based out of Meridian, ID. PKG, Inc. is a leading contract design, developer, and manufacturing company for system-level devices with expertise in human-machine interfaces focusing on healthcare, industrial, aerospace and government products. For the past 30 years PKG has been a major contributor in designing and manufacturing numerous and diverse devices for Fortune 500 companies, mid-size organizations, and start-up businesses. With complete in-house vertical integration, PKG provides its customers with all of their product development needs from R&D, design & development, verification & validation, final product manufacturing, product testing, service and warranty and end of life product support and transitioning.

To Find out the inside Scoop on CBBT Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CBBT

CBBT selected NMS Consulting, Inc. (“NMS”) as its strategic advisor to guide it through its planned acquisition of PKG, Inc. (“PKG”). As part of the initial scope of services, NMS shall provide management consulting services related to the formal due diligence of the PKG operations and financials in addition to analysis related to revenue and cost synergies/savings, human capital and performance optimization, tax advisory, and mitigation strategy, risk management strategy, transaction and financing structuring to ensure optimal benefits to Cerebain and its shareholders. Additional services shall include post-merger integration, revenue growth strategies, market entry and expansion, digital transformation, cyber-security, and data privacy.

PKG inc, just announced a joint agreement with Adventus Venture, a medical device incubator, to finalize development and manufacturing plans for two companies in their portfolio: Allevion Therapeutics and Pressao Medical. Allevion Therapeutics and Pressao Medical are part of the portfolio of Adventus Ventures, LLC, a medical device venture capital company.

Almir Garibovic, CEO of PKG commented: “For the last five years, PKG has been diligently working to strengthen our position as a future leader in state-of-the-art medical, aerospace, industrial and government product development and manufacturing. We are excited to continue delivering innovative products that enable us to fulfill our vision and values. As PKG is in the final stages of joining Cerebain Biotech Corporation, we are very eager to continue investing in promising start-up companies. With the addition of these highly sophisticated products for Allevion Therapeutics and Pressao Medical, we will ensure that our vision and long-term strategy are aligned with Cerebain Biotech Corporation. Once the merger is complete, we intend to add several more start-up companies to our investment portfolio in the near future.”

We have a Monster Pick Coming. Subscribe Right Now

Currently running northbound CBBT is an exciting story in small caps; the Company is in the process of acquiring PKG, Inc., a developer, and manufacturing company for system-level devices with expertise in human-machine interfaces focusing on healthcare, industrial, aerospace and government products. For the past 30 years PKG has been a major contributor in designing and manufacturing numerous and diverse devices for Fortune 500 companies, mid-size organizations, and start-up businesses. CBBT has just 643 Million shares outstanding with OS topped at 1.25 million. We will be updating on CBBT when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CBBT.

Disclosure: we hold no position in CBBT either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.